Evidence map›Paper›PMID 28629353›Full record

ArticleBMC anesthesiology2017

Lipid emulsion mitigates impaired pulmonary function induced by limb I/R in rats through attenuation of local cellular injury and the subsequent systemic inflammatory response/inflammation.

Fangfang Xia, Yun Xia, Sisi Chen, Lulu Chen, Weijuan Zhu, Yuanqing Chen, Thomas J Papadimos, Xuzhong Xu, Le Liu

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC anesthesiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Fluid Therapy During Cardiopulmonary Resuscitation.Frontiers in veterinary science · 2020
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Fangfang XiaDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Yun XiaDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Sisi ChenDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Lulu ChenDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Weijuan ZhuDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Yuanqing ChenDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Thomas J PapadimosDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Xuzhong XuDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Le LiuDepartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China. lle2@163.com.ORCID 0000-0002-2820-027X
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLimb ischemia/reperfusion causes inflammation and elicits oxidative stress that may lead to local tissue damage and remote organ such as lung injury. This study investigates pulmonary function after limb ischemia/reperfusion and the protective effect of a lipid emulsion (Intralipid).

methodsTwenty-four rats were divided into three groups: sham operation group (group S), ischemia/reperfusion group (group IR), and lipid emulsion treatment group (group LE). limb ischemia/reperfusion was induced through occlusion of the infrarenal abdominal aorta for 3 h. The microvascular clamp was removed carefully and reperfusion was provided for 3 h.

resultsThe mean arterial pressure in group LE was higher than group IR during the reperfusion period (P = 0.024). The heart rate of both group LE and IR are significantly higher than group S during the ischemia period(P < 0.001, P < 0.001, respectively). The arterial oxygen pressure of group LE was significantly higher than group IR (P = 0.003), the arterial carbon dioxide pressure of group LE were lower than that of group IR (P = 0.005). The concentration of plasma interleukin-6, tumor necrosis factor-α and malondialdehyde in group LE were significantly lower than group IR (P < 0.001, P = 0.009 and 0.029, respectively). The plasma superoxide dismutase activity in group LE was significantly higher than group IR (P = 0.029). The myeloperoxidase activity in lung tissues of group LE was significantly less than group IR (P = 0.046). Both muscle and lung in group IR were damaged seriously, whereas lipid emulsion (Intralipid) effectively reversed the damage. In summary, Intralipid administration resulted in several beneficial effects as compared to group IR, such as the pulmonary gas exchange and inflammatory.

conclusionsThe ischemic/reperfusion injury of limb muscles with resultant inflammatory damage to lung tissue can be mitigated by administration of a lipid emulsion (Intralipid, 20%, 5 ml/kg). The mechanisms attenuating such a physiological may be attributed to reduction of the degree of limb injury through a decrease in the release of local inflammatory mediators, a reduction of lipid peroxidation, and a blunting of the subsequent remote inflammatory response.

Indexed as

Acute Lung InjuryAnimalsCytokinesEmulsionsFat Emulsions, IntravenousLungOxidative StressPeroxidasePhospholipidsRats, Sprague-DawleyReperfusion InjurySoybean OilSuperoxide DismutaseCytokinesEmulsionsFat Emulsions, IntravenousPeroxidasePhospholipidsSoybean Oilsoybean oil, phospholipid emulsionSuperoxide DismutaseIschemia/reperfusion injuryLimbLipid emulsionLung injuryMDA

Identifiers

PMID28629353
PMCPMC5477350
OpenAlexW2630359863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.